Keyphrases
Atrial Fibrillation
72%
N-3 Polyunsaturated Fatty Acids
46%
Ischemic Stroke
44%
Eicosapentaenoic Acid
32%
Docosahexaenoic Acid
30%
Risk of Ischemic Stroke
29%
Atherosclerotic Cardiovascular Disease (ASCVD)
27%
Hazard Ratio
24%
Stroke Risk
18%
European Patients
18%
Confidence Interval
16%
Low Risk
16%
Oral Anticoagulants
16%
α-linolenic Acid
16%
Hemorrhagic Stroke
15%
Adipose Tissue
14%
All-cause Mortality
13%
Peripheral Arterial Disease
12%
Linoleic Acid
12%
European Society of Cardiology
10%
Plant-derived
10%
3-year Follow-up
9%
Lipophilic Index
9%
Adipose Development
9%
Prevention Strategies
9%
3 Fatty Acids
9%
European Heart Rhythm Association
9%
Blood Levels
9%
Dairy Products
9%
Contemporary Management
9%
Real-world Applicability
9%
Renal Impairment
9%
Anthropometric Parameters
9%
Omega-3 Polyunsaturated Fatty Acids
9%
Risk of Death
9%
HAS-BLED
9%
Review Analysis
9%
Bleeding Risk Score
9%
Stroke Prevention
9%
Non-vitamin K Antagonist Oral Anticoagulants
9%
Oral Anticoagulant Therapy
9%
Case-cohort Study
9%
SCD36
9%
Overweight Subjects
9%
Body Surface Area
9%
Absolute Risk
9%
Danish Case
9%
Omega-3
9%
Marine Compounds
9%
Care Pathway
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Brain Ischemia
39%
Omega-3 Fatty Acid
31%
Linolenic Acid
25%
Icosapentaenoic Acid
25%
Docosahexaenoic Acid
23%
Cause of Death
20%
Coronary Artery Atherosclerosis
18%
Peripheral Occlusive Artery Disease
18%
Malignant Neoplasm
17%
Anticoagulant Agent
16%
Adverse Outcome
10%
Brain Hemorrhage
10%
Antivitamin K
9%
Frailty
9%
Polyunsaturated Fatty Acid
9%
Troponin
9%
Digoxin
9%
Cohort Study
9%
Beta Adrenergic Receptor Blocking Agent
9%
Combination Therapy
9%
Congestive Heart Failure
9%
Atherosclerosis
8%
Biological Marker
7%
Cardiovascular Mortality
6%
All Cause Mortality
6%
Medicine and Dentistry
Atrial Fibrillation
100%
Antithrombotic
31%
Apoplexy
18%
Brain Ischemia
15%
Vitamin K Antagonist
14%
Rhythm
12%
Care Pathway
12%
Anticoagulant Therapy
11%
Cerebral Hemorrhage
10%
Major Bleeding
9%
Linolenic Acid
9%
Omega-3 Fatty Acid
9%
Frailty
9%
Cohort Analysis
9%
Cancer
9%
Malignant Neoplasm
9%
Diabetes
9%
Systematic Review
9%
Meta-Analysis
9%
Cohort Effect
9%
Immunoglobulin G
9%
Monoclonal Gammopathy of Undetermined Significance
9%
Congestive Heart Failure
9%
Combination Therapy
9%
Cause of Death
8%
Ischemic Heart Disease
8%
Immunoglobulin M
7%
Icosapentaenoic Acid
7%
Docosahexaenoic Acid
6%
Hazard Ratio
5%
